Views & Analysis The three biggest challenges in lung cancer, and how researc... Despite new paradigm-shifting treatments, lung cancer remains a deadly disease – and improving outcomes requires more than just drug research.
Digital Four ways AI and machine learning will transform healthcare ... From AI assisted robotic surgery to clinical diagnosis, image analysis and administrative tasks, the use of artificial intelligence and machine learning (ML) technologies is increasing with
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.